Systematic reviews of assessment measures and pharmacologic treatments for agitation

Clinical Therapeutics

Volumn 32, Issue 3, 2010, Pages 403-425

  Zeller, Scott L ^a   Rhoades, Robert W ^b  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

^b Steamboat Springs   (United States)

Author keywords

Agitation; Bipolar disorder; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; DROPERIDOL; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; OLANZAPINE; PLACEBO; PROMETHAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGGRESSION; AGITATION; AKATHISIA; ANXIETY; ARTHRALGIA; ASTHENIA; BEHAVIOR DISORDER; BLURRED VISION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; GAIT DISORDER; HUMAN; HYPERKINESIA; HYPERSALIVATION; HYPOTENSION; HYPOXIA; INJECTION SITE PAIN; INSOMNIA; MONOTHERAPY; MUSCLE HYPERTONIA; NAUSEA; NERVOUSNESS; PAIN; PARKINSONISM; PREDICTION; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RESPIRATION DEPRESSION; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SYSTEMATIC REVIEW; URINE RETENTION; VIOLENCE; XEROSTOMIA;

AGGRESSION; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; LORAZEPAM; SEVERITY OF ILLNESS INDEX; VIOLENCE;

EID: 77951888024     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.03.006     Document Type: Review

References (101)

1. Zimbroff DL Pharmacological control of acute agitation: Focus on intramuscular preparations. CNS Drugs. 2008, 22:199-212.
2. Citrome L Atypical antipsychotics for acute agitation. New intramuscular options offer advantages. Postgrad Med. 2002, 112:85-88.
3. Citrome L Atypical antipsychotics for acute agitation. New intramuscular options offer advantages. Postgrad Med. 2002, 112:94-96.
4. Lindenmayer JP The pathophysiology of agitation. J Clin Psychiatry 2000, 61(Suppl 14):5-10.
5. Nordstrom K, Allen MH Managing the acutely agitated and psychotic patient. CNS Spectr. 2007, 12(Suppl 17):5-11.
6. Allen MH, Currier GW Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiatry 2004, 26:42-49.
7. Marco CA, Vaughan J Emergency management of agitation in schizophrenia. Am J Emerg Med. 2005, 23:767-776.
8. Huf G, Alexander J, Allen MH Haloperidol plus promethazine for psychosis induced aggression. Cochrane Database Syst Rev. 2005, (1):CD005146.
9. Battaglia J Pharmacological management of acute agitation. Drugs. 2005, 65:1207-1222.
10. Lesser JM, Hughes S Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: Definitions and treatment options. Geriatrics 2006, 61:14-20.
11. Warren RE, Deary IJ, Frier BM The symptoms of hyperglycaemia in people with insulin-treated diabetes: Classification using principal components analysis. Diabetes Metab Res Rev. 2003, 19:408-414.
12. Citrome L New treatments for agitation. Psychiatr Q. 2004, 75:197-213.
13. D'Amore J, Hung O, Chiang W, Goldfrank L The epidemiology of the homeless population and its impact on an urban emergency department. Acad Emerg Med. 2001, 8:1051-1055.
14. Zun LS, Downey LV Level of agitation of psychiatric patients presenting to an emergency department. Prim Care Companion J Clin Psychiatry 2008, 10:108-113.
15. The Numbers Count: Mental Disorders in America National Institute of Mental Health, Accessed November 18, 2009. http://www.nimh.nih.gov/health/publications/the-numbers-count-mental-disorders-in-america/index.shtml.
16. Pilowsky LS, Ring H, Shine PJ, et al. Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. Br J Psychiatry 1992, 160:831-835.
17. Piechniczek-Buczek J Psychiatric emergencies in the elderly population. Emerg Med Clin North Am. 2006, 24:467-490.
18. Piechniczek-Buczek J Psychiatric emergencies in the elderly population. Emerg Med Clin North Am. 2006, 24:viii.
19. Alderfer BS, Allen MH Treatment of agitation in bipolar disorder across the life cycle. J Clin Psychiatry 2003, 64(Suppl 4):3-9.
20. Zoupanos BN, Bryois C Treatment of agitation in the emergency room [in French]. Rev Med Suisse. 2005, 1:1810-1813.
21. Moritz F, Bauer F, Boyer A, et al. Patients in a state of agitation at the admission service of a Rouen hospital emergency department [in French]. Presse Med. 1999, 28:1630-1634.
22. Bourdinaud V, Pochard F Survey of management methods for patients in a state of agitation at admission and emergency departments in France [in French]. Encephale. 2003, 29:89-98.
23. Verma SD, Davidoff DA, Kambhampati KK Management of the agitated elderly patient in the nursing home: The role of the atypical antipsychotics. J Clin Psychiatry 1998, 59(Suppl 19):50-55.
24. Downey LV, Zun LS, Gonzales SJ Frequency of alternative to restraints and seclusion and uses of agitation reduction techniques in the emergency department. Gen Hosp Psychiatry 2007, 29:470-474.
25. Agitation Citrome L. Pharmacologic treatment of agitation. Emergency Psychiatry: Principles and Practice 2008, 137-147. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa. R.L. Glick, A.B. Berlin, A.B. Fishkind, S.L. Zeller (Eds.).
26. Perlman CM, Hirdes JP The aggressive behavior scale: A new scale to measure aggression based on the minimum data set. J Am Geriatr Soc. 2008, 56:2298-2303.
27. Corrigan JD Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychol. 1989, 11:261-277.
28. Finkel SI, Lyons JS, Anderson RL A brief agitation rating scale (BARS) for nursing home elderly. J Am Geriatr Soc. 1993, 41:50-52.
29. Lasalvia A, Bonetto C, Cristofalo D, et al. Predicting clinical and social outcome of patients attending 'real world' mental health services: A 6-year multi-wave follow-up study. Acta Psychiatr Scand Suppl. 2007, 16-30.
30. Almvik R, Woods P, Rasmussen K The Brøset Violence Checklist. Sensitivity, specificity, and interrater reliability. J Interpers Violence. 2000, 15:1284-1296.
31. Huber CG, Lambert M, Naber D, et al. Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients. Schizophr Res. 2008, 100:342-348.
32. Cohen-Mansfield J Conceptualization of agitation: Results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument. Int Psychogeriatr. 1996, 8(Suppl 3):309-315.
33. Shah A, Evans H, Parkash N Evaluation of three aggression/agitation behaviour rating scales for use on an acute admission and assessment psychogeriatric ward. Int J Geriatr Psychiatry 1998, 13:415-420.
34. Douglas KS, Guy LS, Weir J HCR-20 violence risk assessment scheme: Overview and annotated bibliography Accessed December 25, 2009. http://www.violence-risk.com/hcr20annotated.pdf.
35. McNiel DE, Binder RL Screening for risk of inpatient violence. Law Hum Behav. 1994, 18:579-586.
36. Vanier M, Mazaux JM, Lambert J, et al. Assessment of neuropsychologic impairments after head injury: Interrater reliability and factorial and criterion validity of the Neuro-behavioral Rating Scale-Revised. Arch Phys Med Rehabil. 2000, 81:796-806.
37. McCauley SR Neurobehavioral Rating Scale-revised 2009, Accessed December 25, 2009. http://docs.google.com/viewer?a=v&q=cache:ot2tT7tiT9AJ:www.nihtoolbox.org/Toolbox%2520test/Neurobehavioral%2520Rating%2520Scale-R.pdf+mccauley,+neurobehavioral+rating+scale+revised&hl=en&gl=us&sig=AHIEtbS9aYwd3dS-F7kU9je4kijqz7VqDw.
38. Yudofsky SC, Silver JM, Jackson W, et al. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986, 143:35-39.
39. McNiel DE, Gregory AL, Lam JN, et al. Utility of decision support tools for assessing acute risk of violence. J Consult Clin Psychol. 2003, 71:945-953.
40. Yudofsky SC, Kopecky HJ, Kunik M, et al. The Overt Agitation Severity Scale for the objective rating of agitation. J Neuropsychiatry Clin Neurosci. 1997, 9:541-548.
41. Kopecky HJ, Kopecky CR, Yudofsky SC Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients. Psychiatr Q. 1998, 69:301-323.
42. Sachs GS, Gaulin BD, Gutierrez-Esteinou R, et al. Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. J Clin Psychiatry 2007, 68:1377-1383.
43. Currier GW, Citrome LL, Zimbroff DL, et al. Intramuscular aripiprazole in the control of agitation. J Psychiatr Pract. 2007, 13:159-169.
44. Marder SR, West B, Lau GS, et al. Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: A post hoc analysis of 4 randomized, placebo-controlled clinical trials. J Clin Psychiatry 2007, 68:662-668.
45. Breier A, Meehan K, Birkett M, et al. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 2002, 59:441-448.
46. Chaichan W Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication. J Psychiatr Pract. 2008, 14:105-113.
47. Ryden MB Aggressive behavior in persons with dementia who live in the community. Alzheimer Dis Assoc Disord. 1988, 2:342-355.
48. Gibbons P, Gannon M, Wrigley M A study of aggression among referrals to a community-based psychiatry of old age service. Int J Geriatr Psychiatry 1997, 12:384-388.
49. Oh H, Eom M, Kwon Y A study on aggressive behavior among nursing home residents with cognitive impairment. Taehan Kanho Hakhoe Chi. 2004, 34:1451-1459.
50. Villari V, Rocca P, Fonzo V, et al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:405-413.
51. Currier GW, Trenton AJ, Walsh PG, van Wijngaarden E A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. J Psychiatr Pract. 2006, 12:223-228.
52. Currier GW, Chou JC, Feifel D, et al. Acute treatment of psychotic agitation: A randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry 2004, 65:386-394.
53. Kinon BJ, Stauffer VL, Kollack-Walker S, et al. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. J Clin Psychopharmacol. 2008, 28:601-607.
54. Kinon BJ, Ahl J, Rotelli MD, McMullen E Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. Am J Emerg Med. 2004, 22:181-186.
55. Veser FH, Veser BD, McMullan JT, et al. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: A pilot, randomized, double-blind, placebo-controlled trial. J Psychiatr Pract. 2006, 12:103-108.
56. Baker RW, Kinon BJ, Maguire GA, et al. Effectiveness of rapid initial dose escalation of up to forty milli- grams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol. 2003, 23:342-348.
57. Meehan KM, Wang H, David SR, et al. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: A double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 2002, 26:494-504.
58. Agid O, Kapur S, Warrington L, et al. Early onset of antipsychotic re sponse in the treatment of acutely agitated patients with psychotic disorders. Schizophr Res. 2008, 102:241-248.
59. Daniel DG, Potkin SG, Reeves KR, et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: A double-blind, randomized trial. Psychopharmacology (Berl) 2001, 155:128-134.
60. Barak Y, Mazeh D, Plopski I, Baruch Y Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. Am J Geriatr Psychiatry 2006, 14:629-633.
61. Wright P, Birkett M, David SR, et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 2001, 158:1149-1151.
62. Damsa C, Adam E, Lazignac C, et al. Intramuscular olanzapine in patients with schizophrenia: An observational study in an emergency room. Bull Soc Sci Med Grand Duche Luxemb. 2008, 209-216.
63. Centorrino F, Meyers AL, Ahl J, et al. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder. Hum Psychopharmacol. 2007, 22:455-462.
64. San L, Arranz B, Querejeta I, et al. A naturalistic multicenter study of intramuscular olanzapine in the treat- ment of acutely agitated manic or schizophrenic patients. Eur Psychiatry 2006, 21:539-543.
65. Meehan K, Zhang F, David S, et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol. 2001, 21:389-397.
66. Tran-Johnson TK, Sack DA, Marcus RN, et al. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: A randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2007, 68:111-119.
67. Andrezina R, Josiassen RC, Marcus RN, et al. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: A double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology (Berl) 2006, 188:281-292.
68. Martel M, Sterzinger A, Miner J, et al. Management of acute undifferentiated agitation in the emergency department: A randomized doubleblind trial of droperidol, ziprasidone, and midazolam [published correction appears in Acad Emerg Med. 2006;13:233]. Acad Emerg Med. 2005, 12:1167-1172.
69. Resnick M, Burton BT Droperidol vs. haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry 1984, 45:298-299.
70. Nobay F, Simon BC, Levitt MA, Dresden GM A prospective, doubleblind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients. Acad Emerg Med. 2004, 11:744-749.
71. Huf G, Coutinho ES, Adams CE Rapid tranquillisation in psychiatric emergency settings in Brazil: Prag- matic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ 2007, 335:869. TREC Collaborative Group.
72. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: A randomised trial of midazolam versus haloperidol plus promethazine. BMJ 2003, 327:708-713. TREC Collaborative Group.
73. Raveendran NS, Tharyan P, Alexander J, Adams CE Rapid tranquillisation in psychiatric emergency settings in India: Pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 2007, 335:865. TREC-India II Collaborative Group.
74. Bieniek SA, Ownby RL, Penalver A, Dominguez RA A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 1998, 18:57-62.
75. Battaglia J, Moss S, Rush J, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 1997, 15:335-340.
76. Knott JC, Taylor DM, Castle DJ Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Ann Emerg Med. 2006, 47:61-67.
77. Richards JR, Derlet RW, Duncan DR Methamphetamine toxicity: Treatment with a benzodiazepine versus a butyrophenone. Eur J Emerg Med. 1997, 4:130-135.
78. Richards JR, Derlet RW, Duncan DR Chemical restraint for the agitated patient in the emergency department: Lorazepam versus droperidol. J Emerg Med. 1998, 16:567-573.
79. Rosen CL, Ratliff AF, Wolfe RE, et al. The efficacy of intravenous droperidol in the prehospital setting. J Emerg Med. 1997, 15:13-17.
80. Citrome L Current treatments of agitation and aggression Accessed November 18, 2009. http://cme.medscape.com/viewprogram/1866.
81. Agitation Fishkind A. Deescalation of the aggressive patient and avoiding coercion. Emergency Psychiatry: Principles and Practice 2008, 125-136. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa. R.L. Glick, A.B. Berlin, A.B. Fishkind, S.L. Zeller (Eds.).
82. Woods DL, Rapp CG, Beck C Escalation/de-escalation patterns of behavioral symptoms of persons with dementia. Aging Ment Health 2004, 8:126-132.
83. Zeller S, Bruch SM Agitation I: Overview of agitation and violence. Emergency Psychiatry: Principles and Practice 2008, 117-124. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa. R.L. Glick, A.B. Berlin, A.B. Fishkind, S.L. Zeller (Eds.).
84. Cohen-Mansfield J Cohen-Mansfield Agitation Inventory (CMAI)-long form Accessed December 25, 2009. http://wanderingnetwork.co.uk/Cohen%20Mansfield%20Agitation%20Inventory.pdf.
85. Abderhalden C, Needham I, Dassen T, et al. Predicting inpatient violence using an extended version of the Br0set-Violence-Checklist: Instrument development and clinical application. BMC Psychiatry 2006, 6:17.
86. Chou KR, Lu RB, Mao WC Factors relevant to patient assaultive behavior and assault in acute inpatient psychiatric units in Taiwan. Arch Psychiatr Nurs. 2002, 16:187-195.
87. Perkins DO Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002, 63:1121-1128.
88. Amore M, Menchetti M, Tonti C, et al. Predictors of violent behavior among acute psychiatric patients: Clinical study. Psychiatry Clin Neurosci. 2008, 62:247-255.
89. Palmstierna T, Huitfeldt B, Wistedt B The relationship of crowding and aggressive behavior on a psychiatric intensive care unit. Hosp Community Psychiatry 1991, 42:1237-1240.
90. Haim R, Rabinowitz J, Lereya J, Fennig S Predictions made by psychiatrists and psychiatric nurses of violence by patients. Psychiatr Serv. 2002, 53:622-624.
91. Allen MH, Carpenter D, Sheets JL, et al. What do consumers say they want and need during a psychiatric emergency?. J Psychiatr Pract. 2003, 9:39-58.
92. Zimbroff DL Clinical management of agitation Accessed November 18, 2009. http://cme.medscape.com/viewprogram/2311.
93. Allen MH, Currier GW, Carpenter D, et al. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract. 2005, 11(Suppl 1):5-108. Expert Consensus Panel for Behavioral Emergencies 2005.
94. Allen MH, Currier GW, Hughes DH, et al. Treatment of behavioral emergencies: A summary of the expert consensus guidelines. J Psychiatr Pract. 2003, 9:16-38.
95. Lukens TW, Wolf SJ, Edlow JA, et al. Clinical policy: Critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med. 2006, 47:79-99. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department.
96. Murphy MC The agitated psychotic patient: Guidelines to ensure staff and patient safety. J Am Psychiatr Nurses Assoc. 2002, 8(Suppl 4):S2-S8.
97. Bartkó G New formulations of olanzapine in the treatment of acute agitation [in Hungarian]. Neuropsychopharmacol Hung. 2006, 8:171-178.
98. Fisman DN, Harris AD, Sorock GS, Mittleman MA Sharps-related injuries in health care workers: A casecrossover study. Am J Med. 2003, 114:688-694.
99. Huf G, Coutinho ES, Adams CE TREC-Rio trial: A randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243]. BMC Psychiatry 2002, 2:11. TREC-Rio Trial.
100. Pascual JC, Madre M, Puigdemont D, et al. A naturalistic study: 100 Consecutive episodes of acute agitation in a psychiatric emergency department [in Spanish]. Actas Esp Psiquiatr. 2006, 34:239-244.
101. Hopewell S, Loudon K, Clarke MJ, et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009, (1):MR000006.